STK15 (STK6) gene polymorphism and methods of determining cancer risk

   
   

The present invention provides methods for determining cancer susceptibility in a human subject by identifying in a nucleic acid sample from the subject, a nucleotide occurrence of a single nucleotide polymorphism (SNP) of the STK15 gene, including the STK15 Ile31 polymorphism. The invention provides isolated polynucleotides, polypeptides, specific binding pair members, and cells useful for identifying agents that affect tumor susceptibility. Furthermore, the invention provides methods for detecting low penetrance tumor susceptibility genes.

La actual invención proporciona los métodos para determinar susceptibilidad del cáncer en un tema humano identificando en una muestra del ácido nucleic del tema, una ocurrencia del nucleotide de un solo polimorfismo del nucleotide (SNP) del gene STK15, incluyendo el polimorfismo de STK15 Ile31. La invención proporciona polynucleotides aislados, los polipéptidos, los miembros obligatorios específicos del par, y las células útiles para identificar los agentes que afectan susceptibilidad del tumor. Además, la invención proporciona los métodos para detectar genes bajos de la susceptibilidad del tumor del penetrance.

 
Web www.patentalert.com

< Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1

< Nucleic acids encoding human serpin polypeptide HMCIS41

> Compositions and methods relating to lung specific genes and proteins

> Human glycosylation enzymes

~ 00172